IPRASENSE
PrivateLast Round
Grant
Nov 1, 2021
Total Funding Raised
$1.89M
Company Overview
IPRASENSE is a life sciences company that develops and commercializes innovative cell culture monitoring equipment, including automated cell counters and viability analyzers.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Imaging, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IPRASENSE Comparables
Compare IPRASENSE with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phase Holographic Imaging AB | 81% | |
| Aligned Genetics | 79% | |
| Nanolive SA | 77% | |
IPRASENSE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2021 | ||||
| Accelerator | Jul 1, 2019 | ||||
| Grant | May 1, 2018 |
IPRASENSE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovative Health Initiative | Grant |
| European Commission | Grant |
| SATT AxLR | Accelerator |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2025
Monthly visitors increased 49% MoM.
- Oct 28, 2024
Monthly visitors grew 49% MoM, reaching 972.
IPRASENSE Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about IPRASENSE's valuation, stock price, and market status.